Biodexa Pharmaceuticals Plc (BDRX)

NASDAQ: BDRX · IEX Real-Time Price · USD

1.300

+0.580 (80.56%)

At close: Apr 26, 2024, 4:00 PM

1.250

-0.050 (-3.85%)

After-hours: Apr 26, 2024, 4:27 PM EDT

Biodexa Pharmaceuticals Income Statement

Financials in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Revenue	0.38	0.7	0.58	0.34	0.67	1.94	0.99	1.32	1.38	0.16	Upgrade
Revenue Growth (YoY)	-45.49%	20.93%	68.51%	-49.11%	-65.22%	95.96%	-25.25%	-3.78%	775.80%	6.80%	Upgrade
Cost of Revenue	0	0	0	0	0	0	0	0	0.07	0	Upgrade
Gross Profit	0.38	0.7	0.58	0.34	0.67	1.94	0.99	1.32	1.31	0.16	Upgrade
Selling, General & Admin	4.34	4.54	2.95	4.96	4.16	4.39	4.44	3.25	5.51	4.41	Upgrade
Research & Development	4.07	5.11	4.65	6.07	7.84	9.36	8.33	7.73	8.71	3.64	Upgrade
Other Operating Expenses	-0.01	-0.02	-0.02	12.36	-0.02	0	1.5	0	0	1.8	Upgrade
Operating Expenses	8.4	9.63	7.58	23.38	11.99	13.75	14.27	10.98	14.22	9.84	Upgrade
Operating Income	-8.01	-8.93	-7	-23.04	-11.32	-11.82	-13.28	-9.65	-12.92	-9.69	Upgrade
Interest Expense / Income	0.04	0.05	0.04	0.43	0.1	0.59	0.11	0.07	0.01	0.16	Upgrade
Other Expense / Income	-0.57	-0.5	-0.94	-0	0.46	4.66	3.94	12.66	-1.69	-0.01	Upgrade
Pretax Income	-7.49	-8.49	-6.11	-23.47	-11.87	-17.06	-17.33	-22.39	-11.23	-9.84	Upgrade
Income Tax	-0.41	-0.83	-0.65	-1.28	-1.79	-2.03	-1.27	-2.23	-1.13	-1.02	Upgrade
Net Income	-7.08	-7.66	-5.46	-22.19	-10.09	-15.03	-16.06	-20.16	-10.1	-8.82	Upgrade
Shares Outstanding (Basic)	278	5	3	1	1	1	0	0	0	0	Upgrade
Shares Outstanding (Diluted)	-	-	-	-	-	-	-	-	-	0	Upgrade
Shares Change	5544.47%	56.16%	131.18%	122.96%	0.16%	25.43%	45.51%	-	133.95%	178.73%	Upgrade
EPS (Basic)	-8.00	-620.00	-544.00	-41.44	-4400.00	-39360.00	-50080.00	-22400.00	-14400.00	-39200.00	Upgrade
EPS (Diluted)	-8.00	-620.00	-544.00	-41.44	-4400.00	-39360.00	-50080.00	-22400.00	-14400.00	-39200.00	Upgrade
Free Cash Flow	-7.69	-7.77	-7.44	-11.32	-8.72	-15.03	-15.12	-16.08	-13.99	-7.28	Upgrade
Free Cash Flow Per Share	-11.07	-630.95	-944.04	-3319.49	-5700.17	-9844.13	-12414.92	-19222.23	-16719.50	-20353.11	Upgrade
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	94.91%	100.00%	Upgrade
Operating Margin	-2103.41%	-1277.83%	-1210.73%	-6717.20%	-1679.23%	-609.65%	-1342.37%	-729.55%	-939.49%	-6170.06%	Upgrade
Profit Margin	-1858.01%	-1095.28%	-944.64%	-6469.10%	-1496.29%	-775.54%	-1624.27%	-1523.96%	-734.47%	-5619.11%	Upgrade
Free Cash Flow Margin	-2019.16%	-1111.30%	-1287.72%	-3300.58%	-1293.62%	-775.70%	-1528.31%	-1215.65%	-1017.38%	-4636.31%	Upgrade
EBITDA	-7.16	-8.1	-5.66	-21.83	-10.49	-15.46	-16.24	-21.54	-10.73	-9.36	Upgrade
EBITDA Margin	-1880.31%	-1158.08%	-979.07%	-6365.01%	-1556.53%	-797.68%	-1641.76%	-1628.42%	-780.07%	-5960.51%	Upgrade
Depreciation & Amortization	0.28	0.34	0.4	1.21	1.28	1.02	0.98	0.77	0.5	0.32	Upgrade
EBIT	-7.44	-8.44	-6.06	-23.04	-11.77	-16.48	-17.22	-22.32	-11.23	-9.68	Upgrade
EBIT Margin	-1953.81%	-1206.72%	-1048.79%	-6716.91%	-1746.74%	-850.10%	-1741.15%	-1686.77%	-816.51%	-6164.97%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).